Dr. Nilah Ioannidis, Departments of Biomedical Data Science and Genetics, Stanford University

Date
Tuesday February 13, 2018
Location
Soda Hall
About this event

Abstract: Understanding the clinical significance of personal genome variation is a major challenge for personalized medicine, with large numbers of variants of unknown significance discovered in next-generation sequencing studies. I will first discuss two machine learning tools that we recently developed to predict the clinical significance of individual genetic variants. REVEL is a random...